Načítá se...
Renal effects of SGLT2 inhibitors: an update
PURPOSE OF REVIEW: SGLT2 inhibitors are a new class of antihyperglycemic drugs that protect kidneys and hearts of type 2 diabetic (T2DM) patients with preserved kidney function from failing. Here we discuss new insights on renal protection. RECENT FINDINGS: Also in T2DM patients with CKD, SGLT2 inhi...
Uloženo v:
| Vydáno v: | Curr Opin Nephrol Hypertens |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7224333/ https://ncbi.nlm.nih.gov/pubmed/31815757 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MNH.0000000000000584 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|